Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Medical Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Nov 11, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
